Germline BRCA Pathogenic Variants and Hematologic Adverse Events in Patients with Ovarian Carcinoma Receiving PARP Inhibitors: a Retrospective Cohort Study
ONCOLOGIST(2024)
Key words
germline BRCA pathogenic variants,hematologic adverse events,advanced high-grade ovarian carcinoma,PARP inhibitors
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined